Biomea Fusion Company Insiders

BMEA Stock  USD 1.18  0.08  6.35%   
About 58% of Biomea Fusion's corporate insiders are selling. The analysis of the overall insider sentiment regarding Biomea Fusion suggests that many insiders are alarmed. Biomea Fusion employs about 42 people. The company is managed by 14 executives with a total tenure of roughly 98 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive.

Insider Sentiment 42

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2024-09-30Michael J.M. HitchcockAcquired 10000 @ 10.06View
2023-05-31A2a Pharmaceuticals, Inc.Disposed 75000 @ 33.81View
2023-05-12A2a Pharmaceuticals, Inc.Disposed 25000 @ 33.84View
2023-05-08A2a Pharmaceuticals, Inc.Disposed 100000 @ 33.99View
2023-04-20A2a Pharmaceuticals, Inc.Disposed 200000 @ 29.12View
2023-03-30Bihua ChenAcquired 400000 @ 30View
2022-11-14Michael J.M. HitchcockAcquired 5000 @ 7.93View
Monitoring Biomea Fusion's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.

Biomea Fusion Management Team Effectiveness

The company has return on total asset (ROA) of (0.7522) % which means that it has lost $0.7522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.09) %, meaning that it created substantial loss on money invested by shareholders. Biomea Fusion's management efficiency ratios could be used to measure how well Biomea Fusion manages its routine affairs as well as how well it operates its assets and liabilities. As of January 29, 2026, Return On Tangible Assets is expected to decline to -1.64. The current year's Return On Capital Employed is expected to grow to -2.7. At present, Biomea Fusion's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 12.1 M, whereas Net Tangible Assets are forecasted to decline to about 80.4 M.
As of January 29, 2026, Common Stock Shares Outstanding is expected to decline to about 26.5 M. The current year's Net Loss is expected to grow to about (70 M)Biomea Fusion holds a total of 70.7 Million outstanding shares. 30% of Biomea Fusion outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2020-03-31
Previous Quarter
40.6 M
Current Value
40.6 M
Avarage Shares Outstanding
29.8 M
Quarterly Volatility
8.7 M
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Biomea Fusion in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biomea Fusion, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Biomea Fusion Workforce Comparison

Biomea Fusion is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,020. Biomea Fusion holds roughly 42.0 in number of employees claiming about 4% of equities under Health Care industry.

Biomea Fusion Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomea Fusion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomea Fusion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biomea Fusion insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biomea Fusion Notable Stakeholders

A Biomea Fusion stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biomea Fusion often face trade-offs trying to please all of them. Biomea Fusion's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biomea Fusion's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Franco CPACFO OfficerProfile
Michael HitchcockInterim DirectorProfile
Juan MDChief OfficerProfile
Caroline DupontSenior ContractsProfile
Stephan MDChief OfficerProfile
Franco ValleCFO OfficerProfile
Ravi UpasaniExecutive PropertyProfile
Ramses ErdtmannPresident, CoFounderProfile
Thomas ButlerChairman CoFounderProfile
Thorsten KirschbergExecutive ChemistryProfile
Alex CacoveanVice SciencesProfile
Naomi CretcherChief OfficerProfile
Heow TanChief OfficerProfile
Caroline JDSenior ContractsProfile
String symbol = request.getParameter("s");

About Biomea Fusion Management Performance

The success or failure of an entity such as Biomea Fusion often depends on how effective the management is. Biomea Fusion management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biomea management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biomea management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.56)(1.64)
Return On Capital Employed(2.84)(2.70)
Return On Assets(1.56)(1.64)
Return On Equity(3.09)(2.93)
Please note, the presentation of Biomea Fusion's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.

Biomea Fusion Workforce Analysis

Traditionally, organizations such as Biomea Fusion use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biomea Fusion within its industry.

Biomea Fusion Manpower Efficiency

Return on Biomea Fusion Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee3.3M
Net Loss Per Executive9.9M
Working Capital Per Employee1.1M
Working Capital Per Executive3.3M

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing